Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manabu Morimoto

Showing results (71-80 of 160) with videos related to

Pageof 16
Sort By:
BMC Cancer|February 22, 2023
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational studySatoshi Kobayashi, Shun Tezuka, Yui Yamachika, et al.
European Journal of Radiology|February 23, 2011
Findings of multidetector row computed tomography of HCCs treated by HIFU ablationHiroyuki Fukuda, Kazushi Numata, Akito Nozaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 26, 2011
Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenibManabu Morimoto, Kazushi Numata, Masaaki Kondo, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 19, 2016
Duodenal stenting followed by systemic chemotherapy for patients with pancreatic cancer and gastric outlet obstructionSatoshi Kobayashi, Makoto Ueno, Ryo Kameda, et al.
Medicine|March 25, 2021
Sofosbuvir-based therapies associated with regression of liver fibrosis in patients with hepatitis C virus infection: A prospective observational studyAkito Nozaki, Makoto Chuma, Koji Hara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Radiofrequency ablation and percutaneous ethanol injection in patients with unresectable hepatocellular carcinoma--a comparative study using Japan Integrated Staging Score (JIS score) system]Manabu Morimoto, Kazushi Numata, Kazuya Sugimori, et al.
Radiology|April 3, 2014
Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysisHiroyuki Fukuda, Kazushi Numata, Satoshi Moriya, et al.
American Journal of Cancer Research|November 13, 2018
Predictive value of ERCC1, ERCC2, ERCC4, and glutathione S-Transferase Pi expression for the efficacy and safety of FOLFIRINOX in patients with unresectable pancreatic cancerShun Tezuka, Makoto Ueno, Satoshi Kobayashi, et al.
Japanese Journal of Clinical Oncology|October 5, 2017
Switch to miriplatin for multinodular hepatocellular carcinoma unresponsive to transarterial chemoembolization with epirubicin: a prospective studyYoshihiro Goda, Manabu Morimoto, Kuniyasu Irie, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[Radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma--CT examination during the follow-up period]Kazuya Sugimori, Kazushi Numata, Manabu Morimoto, et al.
Pageof 16

Showing results (71-80 of 160) with videos related to

Sort By:
Pageof 16
BMC Cancer|February 22, 2023
FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational studySatoshi Kobayashi, Shun Tezuka, Yui Yamachika, et al.
European Journal of Radiology|February 23, 2011
Findings of multidetector row computed tomography of HCCs treated by HIFU ablationHiroyuki Fukuda, Kazushi Numata, Akito Nozaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 26, 2011
Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenibManabu Morimoto, Kazushi Numata, Masaaki Kondo, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 19, 2016
Duodenal stenting followed by systemic chemotherapy for patients with pancreatic cancer and gastric outlet obstructionSatoshi Kobayashi, Makoto Ueno, Ryo Kameda, et al.
Medicine|March 25, 2021
Sofosbuvir-based therapies associated with regression of liver fibrosis in patients with hepatitis C virus infection: A prospective observational studyAkito Nozaki, Makoto Chuma, Koji Hara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 2005
[Radiofrequency ablation and percutaneous ethanol injection in patients with unresectable hepatocellular carcinoma--a comparative study using Japan Integrated Staging Score (JIS score) system]Manabu Morimoto, Kazushi Numata, Kazuya Sugimori, et al.
Radiology|April 3, 2014
Hepatocellular carcinoma: concomitant sorafenib promotes necrosis after radiofrequency ablation--propensity score matching analysisHiroyuki Fukuda, Kazushi Numata, Satoshi Moriya, et al.
American Journal of Cancer Research|November 13, 2018
Predictive value of ERCC1, ERCC2, ERCC4, and glutathione S-Transferase Pi expression for the efficacy and safety of FOLFIRINOX in patients with unresectable pancreatic cancerShun Tezuka, Makoto Ueno, Satoshi Kobayashi, et al.
Japanese Journal of Clinical Oncology|October 5, 2017
Switch to miriplatin for multinodular hepatocellular carcinoma unresponsive to transarterial chemoembolization with epirubicin: a prospective studyYoshihiro Goda, Manabu Morimoto, Kuniyasu Irie, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[Radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma--CT examination during the follow-up period]Kazuya Sugimori, Kazushi Numata, Manabu Morimoto, et al.
Pageof 16